| 1. |
Hayflick, L. (1980) Cell aging. Annu. Rev. Gerontol. Geriatr.
1, 26–67.
|
| |
| 2. |
Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature
345, 458–460.
|
| |
| 3. |
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., et al. (1992) Telomere length predicts
replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA
89, 10,114–10,118.
|
| |
| 4. |
Greider, C. W. (1990) Telomeres, telomerase and senescence. Bioessays
12, 363–369.
|
| |
| 5. |
Harley, C. B. (1991) Telomere loss: Mitotic clock or genetic time bomb? Mutat. Res.
256, 271–282.
|
| |
| 6. |
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., and Cech, T. R. (1997) Reverse transcriptase motifs in
the catalytic subunit of telomerase. Science
276, 561–567.
|
| |
| 7. |
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., et al. (1997) hEST2, the putative
human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell
90, 785–795.
|
| |
| 8. |
Hornsby, P. J. Cell proliferation in mammalian aging, in Handbook of the Biology of Aging 5th ed (Masoro, E. J., and Austad, S. N., eds.), Academic Press, San Diego, 2001, pp. 207–266.
|
| |
| 9. |
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. (1994) Cloning of senescent cell-derived inhibitors
of DNA synthesis using an expression screen. Exp. Cell Res.
211, 90–98.
|
| |
| 10. |
Smith, J. R. and Pereira-Smith, O. M. (1996) Replicative senescence: Implications for in vivo aging and tumor suppression.
Science
273, 63–67.
|
| |
| 11. |
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., et al. (1998) Extension of life-span by
introduction of telomerase into normal human cells. Science
279, 349–352.
|
| |
| 12. |
Jiang, X. R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., et al. (1999) Telomerase expression in human somatic
cells does not induce changes associated with a transformed phenotype. Nat. Genet.
21, 111–114.
|
| |
| 13. |
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., et al. (1999) Absence of cancer-associated
changes in human fibroblasts immortalized with telomerase. Nat. Genet.
21, 115–118.
|
| |
| 14. |
Weinberg, R. A. (1998) Telomeres. Bumps on the road to immortality. Nature
396, 23–24.
|
| |
| 15. |
de Lange, T. and DePinho, R. A. (1999) Unlimited mileage from telomerase? Science
283, 947–949.
|
| |
| 16. |
Funk, W. D., Wang, C. K., Shelton, D. N., Harley, C. B., Pagon, G. D., and Hoeffler, W. K. (2000) Telomerase expression restores
dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp. Cell Res.
258, 270–278.
|
| |
| 17. |
Shay, J. W. and Wright, W. E. (2000) The use of telomerized cells for tissue engineering. Nat. Biotechnol.
18, 22–23.
|
| |
| 18. |
Suwa, T., Yang, L., and Hornsby, P. J. (2001) Telomerase activity in primary cultures of normal adrenocortical cells. J. Endocrinol.
170, 677–684.
|
| |
| 19. |
Yang, L., Suwa, T., Wright, W. E., Shay, J. W., and Hornsby, P. J. (2001) Telomere shortening and decline in replicative potential
as a function of donor age in human adrenocortical cells. Mech. Age. Dev.
122, 1685–1694.
|
| |
| 20. |
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998) Both Rb/p16INK4a
inactivation and telomerase activity are required to immortalize human epithelial cells. Nature
396, 84–8.
|
| |
| 21. |
Ramirez, R. D., Passons, C., Rohde, J., Morales, C. P., Herbert, B.-S., Shay, J. W., et al. (2001) Putative telomere-independent
mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev.
15, 398–403.
|
| |
| 22. |
Kim, S. H., Kaminker, P., and Campisi, J. (1999) TIN2, a new regulator of telomere length in human cells. Nat. Genet.
23, 405–412.
|
| |
| 23. |
Forough, R., Xi, Z., MacPhee, M., Friedman, S., Engleka, K. A., Sayers, T., et al. (1993) Differential transforming abilities
of non-secreted and secreted forms of human fibroblast growth factor-1. J. Biol. Chem.
268, 2960–2968.
|
| |
| 24. |
Hornsby, P. J. and McAllister, J. M. Culturing steroidogenic cells, in Methods in Enzymology, Vol. 206 (Waterman, M. R., and Johnson, E. F., eds.), Academic, San Diego, 1991, pp. 371–380.
|
| |
| 25. |
Hornsby, P. J. Culturing steroidogenic cells, in Cell and Tissue Culture: Laboratory Procedures, 17B (Griffiths, J. B., Doyle, A., and Newell, D. G., eds.), Wiley, Chichester, UK, 1994, pp. 7.1–7.9.
|
| |
| 26. |
Miller, A. D. and Chen, F. (1996) Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors
that use multiple receptors for cell entry. J. Virol.
70, 5564–5571.
|
| |
| 27. |
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., et al. (1994) Specific association of
human telomerase activity with immortal cells and cancer. Science
266, 2011–2015.
|
| |
| 28. |
Thomas, M., Yang, L., and Hornsby, P. J. (2000) Formation of normal functional tissue from transplanted adrenocortical cells
expressing telomerase reverse transcriptase. Nat. Biotechnol.
18, 39–42.
|
| |
| 29. |
Thomas, M., Northrup, S. R., and Hornsby, P. J. (1997) Adrenocortical tissue formed by transplantation of normal clones of
bovine adrenocortical cells in scid mice replaces the essential functions of the animals’ adrenal glands. Nat. Med.
3, 978–983.
|
| |
| 30. |
Papaioannou, V. E. and Fox, J. G. (1993) Efficacy of tribromoethanol anesthesia in mice. Lab. Anim. Sci.
43, 189–192.
|
| |
| 31. |
Runkel, S., Hunter, N., and Milas, L. (1991) An intradermal assay for quantification and kinetics studies of tumor angiogenesis
in mice. Radiat. Res.
126, 237–243.
|
| |
| 32. |
Butel, J. S. (1986) SV40 large T-antigen: Dual oncogene. Cancer Surv.
5, 343–365.
|
| |
| 33. |
Thomas, M., Suwa, T., Yang, L., Zhao, L., Hawks, C. L., and Hornsby, P. J. (2002) Cooperation of hTERT, SV40 T antigen and
oncogenic Ras in tumorigenesis: A cell transplantation model using bovine adrenocortical cells. Neoplasia
4, 493–500.
|
| |
| 34. |
Stewart, C. L., Schuetze, S., Vanek, M., and Wagner, E. F. (1987) Expression of retroviral vectors in transgenic mice obtained
by embryo infection. EMBO J.
6, 383–388.
|
| |
| 35. |
Cheng, C. Y., Ryan, R. F., Vo, T. P., and Hornsby, P. J. (1989) Cellular senescence involves stochastic processes causing
loss of expression of differentiated function genes: Transfection with SV40 as a means for dissociating effects of senescence
on growth and on differentiated function gene expression. Exp. Cell Res.
180, 49–62.
|
| |
| 36. |
Cheng, C. Y., Flasch, M. V., and Hornsby, P. J. (1992) Expression of 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase in
fetal human adrenocortical cells transfected with SV40 T antigen. J. Mol. Endocrinol.
9, 7–17.
|
| |
| 37. |
McInerney, J. M., Nawrocki, J. R., and Lowrey, C. H. (2000) Long-term silencing of retroviral vectors is resistant to reversal
by trichostatin A and 5-azacytidine. Gene Ther.
7, 653–663.
|
| |
| 38. |
Everett, N. B. (1949) Autoplastic and homoplastic transplants of the rat adrenal cortex and medulla to the kidney. Anat. Rec.
103, 335–347.
|
| |
| 39. |
Scheumann, G. F.W., Hiller, W. F., Schroder, S., Schurmeyer, T., Klempnauer, J., and Dralle, H. (1989) Adrenal cortex transplantation
after bilateral total adrenalectomy in the rat. Henry Ford Hosp. Med. J.
37, 154–156.
|
| |
| 40. |
Scheumann, G. F. W., Heitmann, P., Teebken, O. E., Mossinger, E., Mellon, S. H., and Pichlmayr, R. (1996) Enzymatic properties
of transplanted glomerulosa cells. World J. Surg.
20, 933–939.
|
| |
| 41. |
Thomas, M. and Hornsby, P. J. (1999) Transplantation of primary bovine adrenocortical cells into scid mice. Mol. Cell. Endocrinol.
153, 125–136.
|
| |
| 42. |
Bosma, M. J., Phillips, R. A., and Schuler, W. The scid Mouse: Characterization and Potential Uses. Springer-Verlag, Berlin, 1989.
|
| |
| 43. |
Martin, A., Valentine, M., Unger, P., Lichtenstein, C, Schwartz, A. E., Friedman, E. W., et al. (1993) Preservation of functioning
human thyroid organoids in the scid mouse: 1. System characterization. J. Clin. Endocrinol. Metab.
77, 305–310.
|
| |
| 44. |
Volpe, R., Akasu, F., Morita, T., Yoshikawa, N., Resetkova, E., Arreaza, G., et al. (1993) New animal models for human autoimmune
thyroid disease. Xenografts of human thyroid tissue in severe combined immunodeficient (SCID) and nude mice. Horm. Metab. Res.
25, 623–627.
|
| |
| 45. |
Cooper, R. N., Irintchev, A., Di Santo, J. P., Zweyer, M., Morgan, J. E., Partridge, T. A., et al. (2001) A new immunodeficient
mouse model for human myoblast transplantation. Hum. Gene Ther.
12, 823–831.
|
| |
| 46. |
Seebach, J. D. and Waneck, G. L. (1997) Natural killer cells in xenotransplantation. Xenotransplantation
4, 201–211.
|
| |
| 47. |
Hornsby, P. J., Thomas, M., Northrup, S. R., Popnikolov, N. P., Wang, X., Tunstead, J. R., et al. (1998) Cell transplantation:
A tool to study adrenocortical cell biology, physiology, and senescence. Endocr. Res.
24, 909–918.
|
| |
| 48. |
Ciancio, S. J., King, S. R., Suwa, T., Thomas, M., Yang, L., Zhang, H., et al. (2000) Transplantation of normal and genetically
modified adrenocortical cells. Endocr. Res.
26, 931–940.
|
| |
| 49. |
Ciancio, S. J., Coburn, M., and Hornsby, P. J. (2000) A cutaneous window allowing in vivo observations of organs and angiogenesis
in the mouse. J. Surg. Res.
92, 228–232.
|
| |
| 50. |
Dunham, W. B. and Waymouth, C. (1976) Intradermal transplantation in mice of small numbers of sarcoma cells followed by tumor
growth and regression. Cancer. Res.
36, 189–193.
|
| |
| 51. |
Cornil, I., Man, S., Fernandez, B., and Kerbel, R. S. (1989) Enhanced tumorigenicity, melanogenesis, and metastases of a human
malignant melanoma after subdermal implantation in nude mice. J. Natl. Cancer Inst.
81, 938–944.
|
| |
| 52. |
Zhang, H. and Hornsby, P. J. (2002) Intradermal cell transplantation in soluble collagen. Cell Transplantation
11, 139–145.
|
| |